Cite
HARVARD Citation
Henry, T. et al. (2018). Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. European heart journal. pp. 2208-2216. [Online].